Literature DB >> 26658047

Organ Dysfunction in the Course of Severe Acute Pancreatitis.

Min Wang1, Ruoqing Lei.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26658047     DOI: 10.1097/MPA.0000000000000450

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  4 in total

1.  The 5-HT3 Receptor Antagonist Ondansetron Attenuates Pancreatic Injury in Cerulein-Induced Acute Pancreatitis Model.

Authors:  Atsushi Tsukamoto; Takuto Sugimoto; Yuta Onuki; Hajime Shinoda; Taiki Mihara; Masatoshi Hori; Tomo Inomata
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

2.  Mortality in acute pancreatitis with persistent organ failure is determined by the number, type, and sequence of organ systems affected.

Authors:  Jorge D Machicado; Amir Gougol; Xiaoqing Tan; Xiaotian Gao; Pedram Paragomi; Ioannis Pothoulakis; Rupjyoti Talukdar; Rakesh Kochhar; Mahesh K Goenka; Aiste Gulla; Jose A Gonzalez; Vikesh K Singh; Miguel Ferreira; Tyler Stevens; Sorin T Barbu; Haq Nawaz; Silvia C Gutierrez; Narcis O Zarnescu; Gabriele Capurso; Jeffrey J Easler; Konstantinos Triantafyllou; Mario Pelaez-Luna; Shyam Thakkar; Carlos Ocampo; Enrique de-Madaria; Gregory A Cote; Bechien U Wu; Darwin L Conwell; Phil A Hart; Gong Tang; Georgios I Papachristou
Journal:  United European Gastroenterol J       Date:  2021-03       Impact factor: 4.623

3.  Continuous blood purification for severe acute pancreatitis: A systematic review and meta-analysis.

Authors:  Yong Hu; Wenjun Xiong; Chunyan Li; Yunfeng Cui
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

4.  Emodin attenuates severe acute pancreatitis-associated acute lung injury by suppressing pancreatic exosome-mediated alveolar macrophage activation.

Authors:  Qian Hu; Jiaqi Yao; Xiajia Wu; Juan Li; Guixiang Li; Wenfu Tang; Jingping Liu; Meihua Wan
Journal:  Acta Pharm Sin B       Date:  2021-10-21       Impact factor: 14.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.